Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 3
2005 3
2006 2
2008 2
2009 4
2011 1
2014 2
2015 1
2016 1
2017 2
2019 2
2020 3
2021 1
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
Makker V, Colombo N, Casado Herráez A, Santin AD, Colomba E, Miller DS, Fujiwara K, Pignata S, Baron-Hay S, Ray-Coquard I, Shapira-Frommer R, Ushijima K, Sakata J, Yonemori K, Kim YM, Guerra EM, Sanli UA, McCormack MM, Smith AD, Keefe S, Bird S, Dutta L, Orlowski RJ, Lorusso D; Study 309–KEYNOTE-775 Investigators. Makker V, et al. N Engl J Med. 2022 Feb 3;386(5):437-448. doi: 10.1056/NEJMoa2108330. Epub 2022 Jan 19. N Engl J Med. 2022. PMID: 35045221 Clinical Trial.
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.
Moore KN, Secord AA, Geller MA, Miller DS, Cloven N, Fleming GF, Wahner Hendrickson AE, Azodi M, DiSilvestro P, Oza AM, Cristea M, Berek JS, Chan JK, Rimel BJ, Matei DE, Li Y, Sun K, Luptakova K, Matulonis UA, Monk BJ. Moore KN, et al. Among authors: miller ds. Lancet Oncol. 2019 May;20(5):636-648. doi: 10.1016/S1470-2045(19)30029-4. Epub 2019 Apr 1. Lancet Oncol. 2019. PMID: 30948273 Clinical Trial.
Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician's Choice.
Lorusso D, Colombo N, Herraez AC, Santin AD, Colomba E, Miller DS, Fujiwara K, Pignata S, Baron-Hay SE, Ray-Coquard IL, Shapira-Frommer R, Kim YM, McCormack M, Massaad R, Nguyen AM, Zhao Q, McKenzie J, Prabhu VS, Makker V. Lorusso D, et al. Among authors: miller ds. Eur J Cancer. 2023 Jun;186:172-184. doi: 10.1016/j.ejca.2023.03.015. Epub 2023 Mar 23. Eur J Cancer. 2023. PMID: 37086595 Free PMC article. Clinical Trial.
Urinary bladder cancer.
Wai CY, Miller DS. Wai CY, et al. Among authors: miller ds. Clin Obstet Gynecol. 2002 Sep;45(3):844-54. doi: 10.1097/00003081-200209000-00031. Clin Obstet Gynecol. 2002. PMID: 12370626 Review. No abstract available.
New therapies for advanced, recurrent, and metastatic endometrial cancers.
Makker V, Green AK, Wenham RM, Mutch D, Davidson B, Miller DS. Makker V, et al. Among authors: miller ds. Gynecol Oncol Res Pract. 2017 Dec 2;4:19. doi: 10.1186/s40661-017-0056-7. eCollection 2017. Gynecol Oncol Res Pract. 2017. PMID: 29214032 Free PMC article. Review.
Pharmacotherapy of endometrial cancer.
Barrena Medel NI, Bansal S, Miller DS, Wright JD, Herzog TJ. Barrena Medel NI, et al. Among authors: miller ds. Expert Opin Pharmacother. 2009 Aug;10(12):1939-51. doi: 10.1517/14656560903061291. Expert Opin Pharmacother. 2009. PMID: 19586421 Review.
Social determinants of health in uterine carcinosarcoma.
Aroche Gutierrez LL, McIntire DD, Lea J, LoCoco S, Miller DS. Aroche Gutierrez LL, et al. Among authors: miller ds. Gynecol Oncol. 2024 Feb 2;184:117-122. doi: 10.1016/j.ygyno.2024.01.042. Online ahead of print. Gynecol Oncol. 2024. PMID: 38309028
Hormonal therapy in epithelial ovarian cancer.
Rao GG, Miller DS. Rao GG, et al. Among authors: miller ds. Expert Rev Anticancer Ther. 2006 Jan;6(1):43-7. doi: 10.1586/14737140.6.1.43. Expert Rev Anticancer Ther. 2006. PMID: 16375643 Review.
33 results